Clariane SE risk profile

45 Elevated one input has moved against it

Measured 1 September 2026 from CLARI's filed statements. Recomputed nightly.

45 (Elevated), driven by Leverage and coverage at 73, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation42ElevatedStableOne-year price volatility — 37.7%
Operating pressure43ElevatedStableCosts outgrowing revenue — +0.1 percentage points
Cash conversion12ContainedEasingCapital spending against operating cash — 0.24x
Leverage and coverage73StretchedEasingNet debt to EBITDA — 6.09x
Competitive position46ElevatedStableRevenue-growth gap against peers — -15.7 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Clariane SE